A novel mutation of Myotilin is associated with muscular dystrophy and postoperative respiratory failure
Open Access
- 19 June 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 116 (10) , 859-860
Abstract
Mutations of myotilin (MYOT) have been identified in patients with muscular dystrophy. We identified a novel mutation (NM_006790: c.849G>A/p.W283X) of MYOT in a family with muscular dystrophy and postoperative respiratory failure. Functional studies revealed that the mutation led to a truncated protein, as the molecular weight was smaller, the expression level was reduced, and the distribution of MYOT was altered.Keywords
Funding Information
- National Natural Science Foundation of China (82000427)
- National Natural Science Foundation of Hunan Province (2023JJ20078)
This publication has 6 references indexed in Scilit:
- Molecular basis of F-actin regulation and sarcomere assembly via myotilinPLOS Biology, 2021
- The Role of Z-disc Proteins in Myopathy and CardiomyopathyInternational Journal of Molecular Sciences, 2021
- Conformational plasticity and evolutionary analysis of the myotilin tandem Ig domainsScientific Reports, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assemblyHuman Molecular Genetics, 2003
- Myotilin is mutated in limb girdle muscular dystrophy 1AHuman Molecular Genetics, 2000